1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Anti-Infective Drug News DECEMBER 2016

Anti-Infective Drug News DECEMBER 2016

  • December 2016
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Predatory Bacteria Have Final Resort Potential
Industry Brief - Zydus Gains FDA Metronidazole Approval
Industry Trend Analysis - Weak Aradigm Results Raises Questions Over Pipeline Potential
Industry Brief - FDA Granted Fast Track Designation For ASN100 To Prevent S.aureus Pneumonia
Industry Brief - Fresenius Kabi's Tigecycline Injection Launched In US
Industry Trend Analysis - Xydalba Will Gain Traction As Drug Resistance Threat Worsens
Industry Brief - Health Canada Approves Pediapharm's Otixal To Treat AOMT
Industry Trend Analysis - Plazomicin Will Find Niche As Infections Adapt To Alternatives
Industry Brief - Valneva Secures US/EU Approvals To Commence VLA15 Phase I Lyme Disease Study
Industry Brief - DSMB Recommends Continuation Of RHB-104 Phase III CD Study
Industry Brief - Matinas Initiates Enrolment/Dosing In MAT2203 Phase II VVC Study
Industry Brief - Dr Reddy Launches Nystatin And Triamcinolone Acetonide Cream In US
Industry Brief - FDA Scientists Develop Neonatal Mouse Model For Accelerating Zika Vaccine Research
Industry Brief - GSK Seeks Approval For Shingrix To Prevent Shingles In Canada
Industry Brief - GSK's FluLaval Quadrivalent Receives FDA Approval For Expanded Indication
Industry Brief - Enrolment Completed In Phase III Non-inferiority Study Of Imvamune Smallpox Vaccine
Industry Brief - GSK Seeks European Marketing Approval For Shingrix To Prevent Shingles
Industry Brief - Takeda To Invest In Dengue Vaccine Manufacturing Plant In Germany
Industry Brief - First Patient Enrolled In Pritelivir Phase II HSV Study
Industry Brief - Mymetics/Sanofi Enter Research Collaboration For Influenza Vaccines
Industry Brief - BiondVax's M-001 Yields Positive Data In European Phase IIb Trial
Industry Brief - IVI To Fund Further Development Of MERS Vaccine GLS-5300 In Korea
Industry Trend Analysis - Tamiflu Generic Launch Will Increase Pandemic Preparedness
Industry Brief - Enrolment Completed In MVA-BN RSV Phase II Trial
Industry Trend Analysis - Injectable HIV Therapy Has Strong Potential In Low Compliance Niche
Industry Trend Analysis - Prequalification Applications Herald A Competitive Dolutegravir Environment
Industry Brief - SRI Awarded NIAID-DAIDS Contract To Develop HIV-Prevention Products
Industry Brief - Lupin Gains FDA Tentative Abacavir+Lamivudine Approval
Industry Trend Analysis - African HIV Vaccine Trial Attempts To Meet Huge Demand
Industry Brief - First Several Patients Treated With CytoDyn's PRO 140 In Phase III HIV Trial
Industry Trend Analysis - New Vaccine Centre Increases GSK's Focus On Novel Candidates
Industry Brief - Adimmune Begins Shipments To EU Of Enoxaparin Sodium PFS
Industry Trend Analysis - Shifts In Anti-Infective Markets May Cause Major Disruptions
Industry Brief - ENYO Pharma Secures EU Grant To Support Project MIMESIS
Industry Trend Analysis - EX1 Collapse Forces Arrowhead Down Risky Path
Industry Brief - Mylan Enters Daclatasvir Agreement With MPP
Industry Brief - Dosing Begins In JNJ-4178 Phase IIb Chronic HCV Study
Industry Brief - Gilead Seeks FDA Approval For SOF/VEL/VOX Combination Regimen In HCV

Table Of Contents

Anti-Infective Drug News DECEMBER 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Cryptococcosis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Cryptococcosis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • February 2017
  • by Transparency Market Research

Global Cryptococcosis Market: Overview This report on the global cryptococcosis market analyzes the current and future scenario of the global market. Cryptococcosis disease burden is rising due to increase ...

Immunotherapy Drugs Market by Type of Drugs, Therapy Area, End-User, Region - Global Forecast to 2021

Immunotherapy Drugs Market by Type of Drugs, Therapy Area, End-User, Region - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The global immunotherapy drugs market is projected to reach USD 201.52 billion by 2021 from USD 108.41 billion in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021. In this report, ...

Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19

Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19

  • $ 4995
  • Industry report
  • November 2016
  • by GBI Research

Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19 Summary Cancer vaccines are being ...


Download Unlimited Documents from Trusted Public Sources

Anti-Infective Market in the US

  • February 2017
    9 pages
  • Anti-Infective  

    Influenza  

  • United States  

View report >

HIV AIDS Statistics and HIV Antiviral Market in China

  • February 2017
    11 pages
  • HIV AIDS  

    Infectious Dise...  

    HIV Antiviral  

  • China  

    United States  

View report >

Chemotherapy Market in the US

  • February 2017
    9 pages
  • Chemotherapy  

  • United States  

View report >

Related Market Segments :

Infectious Disease

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.